News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

Rifampin, phenytoin and carbamazepine should be avoided with ribociclib therapy ... improves survival in post-menopausal women with hormone receptor-positive metastatic breast cancer.

NICE has recommended moving Novartis’ Kisqali (ribociclib ... advanced breast cancer who had previous endocrine therapy. This compared patients treated with Kisqali plus fulvestrant with ...

plus fulvestrant can be used routinely on the NHS as a second-line therapy for patients with advanced hormone receptor-positive, HER2-negative breast cancer who have already been treated with ...

Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, ...

After chemotherapy failure, if the cancer is also resistant to endocrine therapy ... oncologist's choice can directly affect survival outcomes. HER2-low breast cancer does not overexpress the ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

For cancer patients who require radiation therapy, permanent tattoos have long ... The experience of breast cancer patients highlights the emotional toll these tattoos can take.

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

If you’re a frequent Walmart shopper, the perks of a Walmart Plus membership — like free unlimited deliveries and mobile scan and go– can save you time and money, especially during Black ...